<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are the most frequently used <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers in the clinical setting of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This study was designed to investigate the correlation between preoperative serum levels of CA 19-9 (pre-CA 19-9) and the clinicopathologic factors of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A study was performed on 333 patients with histologically diagnosed colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> between December 2008 and November 2011, based on prospective collected data </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical data such as age, sex, location of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, size of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, differentiation, depth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (T), lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (N), distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (M), lymphatic invasion, venous invasion, perineural invasion, stage, and preoperative serum levels of CEA (pre-CEA) and pre-CA 19-9 were obtained </plain></SENT>
<SENT sid="4" pm="."><plain>These patients were classified into two groups according to pre-CA 19-9 (CA 19-9 high: &gt;39 U/mL, n = 61 [18.3%]; CA 19-9 <z:mpath ids='MPATH_458'>normal</z:mpath>: &lt;39 U/mL, n = 272 [81.7%]) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Sixty-one patients among 333 patients (18.3%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> showed a high pre-CA 19-9 </plain></SENT>
<SENT sid="6" pm="."><plain>The elevation of pre-CA 19-9 was significantly associated with size of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (4.8 ± 0.1 cm vs. 6.1 ± 0.3 cm, P &lt; 0.001), right <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (P &lt; 0.001), depth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (P &lt; 0.001), lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P &lt; 0.001), distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P &lt; 0.001), perineural invasion (P = 0.008), peritoneal seeding (P &lt; 0.001), and stage (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>On multivariate analysis, high pre-CA 19-9 was shown to be independently associated with high pre-CEA, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, right <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, and peritoneal seeding </plain></SENT>
<SENT sid="8" pm="."><plain>There were twelve patients confirmed for peritoneal seeding among 333 patients (3.6%) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: High pre-CA 19-9 in advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> might provide important information to predict the possibility of peritoneal seeding </plain></SENT>
</text></document>